Potential treatment could prevent millions of annual heart failures and deaths in severe heart attack patients
A clinical trial in which cardiac patients received intravenous dexrazoxane before, during and after their blocked coronary artery was reopened showed a reduction in bleeding within the heart muscle, intramyocardial hemorrhage ...
Aug 31, 2026
0
7


